NCT06730256View on ClinicalTrials.gov

A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 23, 2025

Primary Completion Date

January 3, 2027

Study Completion Date

December 31, 2027

Conditions
Relapsed/Refractory Plasma Cell LeukemiaRelapsed/Refractory Multiple Myeloma
Interventions
DRUG

CAR-T cells Infusion chimeric antigen receptor T cells

CAR-T cells Infusion chimeric antigen receptor T cells

Trial Locations (1)

215000

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

Sponsors
All Listed Sponsors
collaborator

CARsgen Therapeutics Co., Ltd.

INDUSTRY

lead

The First Affiliated Hospital of Soochow University

OTHER